An economic evaluation of dasatinib as a treatment for chronic phase chronic myeloid leukaemia in Scotland

被引：1
|
作者：
Taylor, M. J. [1 ]
Minda, K. [2 ]
Cerri, K. H. [3 ]
Davis, C. [4 ]
Kan, H. J. [4 ]
Ray, S. [2 ]
机构：
[1] Univ York, York YO10 5DD, N Yorkshire, England
[2] Bristol Myers Squibb Pharmaceut, Uxbridge, Middx, England
[3] Bristol Myers Squibb Co, New York, NY 10154 USA
[4] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)64889-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [21] Dasatinib-induced panniculitis in a patient with chronic myeloid leukaemia
    Yusuke Nagasawa
    Shin Iinuma
    Mizue Fujii
    Kyoko Kanno
    Masaru Honma
    Sayaka Yuzawa
    Akemi Ishida-Yamamoto
    European Journal of Dermatology, 2021, 31 : 87 - 88
  • [22] Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph+ Acute Lymphoblastic Leukaemia
    Gillian M. Keating
    Drugs, 2017, 77 : 85 - 96
  • [23] Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph plus Acute Lymphoblastic Leukaemia
    Keating, Gillian M.
    DRUGS, 2017, 77 (01) : 85 - 96
  • [24] Dasatinib causing Intracerebral Bleeding in a Patient with Chronic Myeloid Leukaemia
    Rathod, Santosh Govind
    Khan, Afaq Ahmad
    Geelani, Sajad Ahmed
    Roshan, Reshma
    Bhat, Javid Rasool
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06)
  • [25] Dasatinib-induced colitis in a patient with chronic myeloid leukaemia
    Gluch, Alexander Edmund
    Subhaharan, Deloshaan
    Pillai, Sooraj
    Ramaswamy, Pradeep Kakkadasam
    BMJ CASE REPORTS, 2025, 18 (01)
  • [26] Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia
    Ross, David M.
    Jackson, Sharon R.
    Browett, Peter J.
    LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1231 - 1233
  • [27] Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia
    Dumitrescu, D.
    Seck, C.
    ten Freyhaus, H.
    Gerhardt, F.
    Erdmann, E.
    Rosenkranz, S.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 218 - 220
  • [28] The blast phase of chronic myeloid leukaemia
    Silver, Richard T.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (03) : 387 - 394
  • [29] EVALUATION OF THE EFFECT AND SAFETY OF PONATINIB AS THIRD-LINE TREATMENT FOR PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE
    Patir, P.
    Uysal, A.
    Duran, M.
    Soyer, N.
    Vural, F.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S28 - S28
  • [30] ECONOMIC EVALUATION OF DASATINIB COMPARED TO NIL OTINIB AS SECOND LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN GREECE
    Gourzoulidis, G.
    Vassilopoulos, G.
    Gialama, F.
    Kourlaba, G.
    Diamantogiannis, F.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A443 - A443
12345